Intestinal diffuse large B-cell lymphoma: An evaluation of different staging systems

Keyphrases

• Ann Arbor 16%
• Chemotherapy Alone 16%
• CHOP Chemotherapy 16%
• CHOP Regimen 16%
• Classification System 16%
• Complete Remission 16%
• Cyclophosphamide 16%
• Diffuse Large B-cell Lymphoma (DLBCL) 100%
• Doxorubicin 16%
• Epithelial Tumor 16%
• Extranodal Sites 16%
• Follow-up Time 16%
• Gastrointestinal Tract 16%
• Lugano 16%
• Multivariate Analysis 16%
• Overall Survival 16%
• Paris 16%
• Paris Classification 33%
• Patient Survival 16%
• Prednisolone 16%
• Primary Extranodal 16%
• Prognostic Indicator 16%
• Prognostic Significance 16%
• Rituximab 33%
• Staging System 100%
• Survival Benefit 16%
• Survival Rate 16%
• T Stage 33%
• Tumor-node-metastasis Staging 16%
• Univariate Analysis 16%

Medicine and Dentistry

• CHOP 33%
• Cyclophosphamide 16%
• Diffuse Large B-Cell Lymphoma 100%
• Doxorubicin 16%
• Epithelioma 16%
• Gastrointestinal Tract 16%
• Immunotherapy 16%
• Metastatic Carcinoma 16%
• Multivariate Analysis 16%
• Neoplasm 16%
• Overall Survival 16%
• Prednisolone 16%
• Rituximab 33%
• Survival Rate 16%
• Univariate Analysis 16%
• Vincristine 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 16%
• Cyclophosphamide 16%
• Diffuse Large B Cell Lymphoma 100%
• Doxorubicin 16%
• Epithelium Tumor 16%
• Immunotherapy 16%
• Neoplasm 16%
• Overall Survival 16%
• Prednisolone 16%
• Remission 16%
• Rituximab 33%
• Survival Rate 16%
• Vincristine 16%